These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 31720408)

  • 41. Xpert MTB/RIF Ultra assay for the detection of Mycobacterium tuberculosis in people with negative conventional Xpert MTB/RIF but chest imaging suggestive of tuberculosis in Dhaka, Bangladesh.
    Biswas S; Uddin MKM; Paul KK; Ather MF; Ahmed S; Nasrin R; Kabir S; Heysell SK; Banu S
    Int J Infect Dis; 2022 Jan; 114():244-251. PubMed ID: 34774779
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Outcome of tuberculosis treatment in HIV-positive adults diagnosed through active versus passive case-finding.
    Balcha TT; Skogmar S; Sturegård E; Björkman P; Winqvist N
    Glob Health Action; 2015; 8():27048. PubMed ID: 25819037
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effect of sputum quality and volume on the yield of bacteriologically-confirmed TB by Xpert MTB/RIF and smear.
    Zimba O; Tamuhla T; Basotli J; Letsibogo G; Pals S; Mathebula U; Mathoma A; Serumola C; Ramogale K; Boyd R; Tran T; Finlay A; Auld A; Date A; Alexander H; Chihota V; Agizew T
    Pan Afr Med J; 2019; 33():110. PubMed ID: 31489088
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Number needed to screen for TB in clinical, structural or occupational risk groups.
    Naufal F; Chaisson LH; Robsky KO; Delgado-Barroso P; Alvarez-Manzo HS; Miller CR; Shapiro AE; Golub JE
    Int J Tuberc Lung Dis; 2022 Jun; 26(6):500-508. PubMed ID: 35650693
    [No Abstract]   [Full Text] [Related]  

  • 45. Market penetration of Xpert MTB/RIF in high tuberculosis burden countries: A trend analysis from 2014 - 2016.
    Cazabon D; Pande T; Kik S; Van Gemert W; Sohn H; Denkinger C; Qin ZZ; Waning B; Pai M
    Gates Open Res; 2018; 2():35. PubMed ID: 30234198
    [No Abstract]   [Full Text] [Related]  

  • 46. Xpert MTB/RIF assay did not improve diagnosis of pulmonary tuberculosis among child contacts in Rwanda.
    Birungi FM; van Wyk B; Uwimana J; Ntaganira J; Graham SM
    Pan Afr Med J; 2018; 30():39. PubMed ID: 30167066
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The performance and yield of tuberculosis testing algorithms using microscopy, chest x-ray, and Xpert MTB/RIF.
    Creswell J; Qin ZZ; Gurung R; Lamichhane B; Yadav DK; Prasai MK; Bista N; Adhikari LM; Rai B; Sudrungrot S
    J Clin Tuberc Other Mycobact Dis; 2019 Feb; 14():1-6. PubMed ID: 31720409
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Strategies to increase childhood tuberculosis case detection at the primary health care level: Lessons from an active case finding study in Zambia.
    Kagujje M; Nyangu S; Maimbolwa MM; Shuma B; Mutti L; Somwe P; Sanjase N; Chungu C; Kerkhoff AD; Muyoyeta M
    PLoS One; 2023; 18(7):e0288643. PubMed ID: 37467209
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Islands of Tuberculosis Elimination: An Evaluation of Community-Based Active Case Finding in North Sumatra, Indonesia.
    Siahaan ES; Bakker MI; Pasaribu R; Khan A; Pande T; Hasibuan AM; Creswell J
    Trop Med Infect Dis; 2020 Oct; 5(4):. PubMed ID: 33114494
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Active case-finding for tuberculosis by mobile teams in Myanmar: yield and treatment outcomes.
    Myint O; Saw S; Isaakidis P; Khogali M; Reid A; Hoa NB; Kyaw TT; Zaw KK; Khaing TMM; Aung ST
    Infect Dis Poverty; 2017 Jun; 6(1):77. PubMed ID: 28571575
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting.
    Theron G; Peter J; van Zyl-Smit R; Mishra H; Streicher E; Murray S; Dawson R; Whitelaw A; Hoelscher M; Sharma S; Pai M; Warren R; Dheda K
    Am J Respir Crit Care Med; 2011 Jul; 184(1):132-40. PubMed ID: 21493734
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Systematic screening for tuberculosis among hospital outpatients in Cameroon: The role of screening and testing algorithms to improve case detection.
    Sander MS; Laah SN; Titahong CN; Lele C; Kinge T; de Jong BC; Abena JF; Codlin AJ; Creswell J
    J Clin Tuberc Other Mycobact Dis; 2019 May; 15():100095. PubMed ID: 31720422
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Early TB case detection by community-based mobile X-ray screening and Xpert testing in Balochistan.
    Wali A; Safdar N; Manair R; Khan MD; Khan A; Kurd SA; Khalil L
    Public Health Action; 2021 Dec; 11(4):174-179. PubMed ID: 34956844
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Xpert
    Kohli M; Schiller I; Dendukuri N; Dheda K; Denkinger CM; Schumacher SG; Steingart KR
    Cochrane Database Syst Rev; 2018 Aug; 8(8):CD012768. PubMed ID: 30148542
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Screening for HIV-associated tuberculosis and rifampicin resistance before antiretroviral therapy using the Xpert MTB/RIF assay: a prospective study.
    Lawn SD; Brooks SV; Kranzer K; Nicol MP; Whitelaw A; Vogt M; Bekker LG; Wood R
    PLoS Med; 2011 Jul; 8(7):e1001067. PubMed ID: 21818180
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The implementation of Xpert MTB/RIF assay for diagnosis of tuberculosis in Nepal: A mixed-methods analysis.
    Joshi B; Lestari T; Graham SM; Baral SC; Verma SC; Ghimire G; Bhatta B; Dumre SP; Utarini A
    PLoS One; 2018; 13(8):e0201731. PubMed ID: 30096174
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Active case finding of rifampicin sensitive and resistant TB among household contacts of drug resistant TB patients in Andhra Pradesh and Telangana states of India - A systematic screening intervention.
    Chatla C; Jaju J; Achanta S; Samyuktha R; Chakramahanti S; Purad C; Chepuri R; Nair SA; Parmar M
    Indian J Tuberc; 2018 Jul; 65(3):218-224. PubMed ID: 29933863
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Xpert MTB/RIF diagnosis of childhood tuberculosis from sputum and stool samples in a high TB-HIV-prevalent setting.
    Orikiriza P; Nansumba M; Nyehangane D; Bastard M; Mugisha IT; Nansera D; Mwanga-Amumpaire J; Boum Y; Kumbakumba E; Bonnet M
    Eur J Clin Microbiol Infect Dis; 2018 Aug; 37(8):1465-1473. PubMed ID: 29740714
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Catching the missing million: experiences in enhancing TB & DR-TB detection by providing upfront Xpert MTB/RIF testing for people living with HIV in India.
    Raizada N; Sachdeva KS; Sreenivas A; Kulsange S; Gupta RS; Thakur R; Dewan P; Boehme C; Paramsivan CN
    PLoS One; 2015; 10(2):e0116721. PubMed ID: 25658091
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.